Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022

HIV testing was offered to 2,185 people receiving mpox (formerly monkeypox) vaccination, who reported not being HIV positive. Among them 390 were current PrEP users, and 131 had taken PrEP in the past. Of 958 individuals consenting testing, six were newly diagnosed with HIV. Two patients had symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Pittalis, Silvia, Mazzotta, Valentina, Orchi, Nicoletta, Abbate, Isabella, Gagliardini, Roberta, Gennaro, Elisabetta, Faticoni, Augusto, Piselli, Pierluca, Rozera, Gabriella, Cicalini, Stefania, Maggi, Fabrizio, Girardi, Enrico, Vaia, Francesco, Antinori, Andrea, Puro, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716645/
https://www.ncbi.nlm.nih.gov/pubmed/36695459
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.48.2200890
_version_ 1784842736586719232
author Pittalis, Silvia
Mazzotta, Valentina
Orchi, Nicoletta
Abbate, Isabella
Gagliardini, Roberta
Gennaro, Elisabetta
Faticoni, Augusto
Piselli, Pierluca
Rozera, Gabriella
Cicalini, Stefania
Maggi, Fabrizio
Girardi, Enrico
Vaia, Francesco
Antinori, Andrea
Puro, Vincenzo
author_facet Pittalis, Silvia
Mazzotta, Valentina
Orchi, Nicoletta
Abbate, Isabella
Gagliardini, Roberta
Gennaro, Elisabetta
Faticoni, Augusto
Piselli, Pierluca
Rozera, Gabriella
Cicalini, Stefania
Maggi, Fabrizio
Girardi, Enrico
Vaia, Francesco
Antinori, Andrea
Puro, Vincenzo
author_sort Pittalis, Silvia
collection PubMed
description HIV testing was offered to 2,185 people receiving mpox (formerly monkeypox) vaccination, who reported not being HIV positive. Among them 390 were current PrEP users, and 131 had taken PrEP in the past. Of 958 individuals consenting testing, six were newly diagnosed with HIV. Two patients had symptomatic primary HIV infection. None of the six patients had ever taken PrEP. Mpox vaccination represents an important opportunity for HIV testing and counselling about risk reduction and PrEP.
format Online
Article
Text
id pubmed-9716645
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-97166452022-12-12 Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022 Pittalis, Silvia Mazzotta, Valentina Orchi, Nicoletta Abbate, Isabella Gagliardini, Roberta Gennaro, Elisabetta Faticoni, Augusto Piselli, Pierluca Rozera, Gabriella Cicalini, Stefania Maggi, Fabrizio Girardi, Enrico Vaia, Francesco Antinori, Andrea Puro, Vincenzo Euro Surveill Rapid Communication HIV testing was offered to 2,185 people receiving mpox (formerly monkeypox) vaccination, who reported not being HIV positive. Among them 390 were current PrEP users, and 131 had taken PrEP in the past. Of 958 individuals consenting testing, six were newly diagnosed with HIV. Two patients had symptomatic primary HIV infection. None of the six patients had ever taken PrEP. Mpox vaccination represents an important opportunity for HIV testing and counselling about risk reduction and PrEP. European Centre for Disease Prevention and Control (ECDC) 2022-12-01 /pmc/articles/PMC9716645/ /pubmed/36695459 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.48.2200890 Text en This article is copyright of the authors or their affiliated institutions, 2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Rapid Communication
Pittalis, Silvia
Mazzotta, Valentina
Orchi, Nicoletta
Abbate, Isabella
Gagliardini, Roberta
Gennaro, Elisabetta
Faticoni, Augusto
Piselli, Pierluca
Rozera, Gabriella
Cicalini, Stefania
Maggi, Fabrizio
Girardi, Enrico
Vaia, Francesco
Antinori, Andrea
Puro, Vincenzo
Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022
title Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022
title_full Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022
title_fullStr Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022
title_full_unstemmed Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022
title_short Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022
title_sort results of an interventional hiv testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in latium region, italy, august to october 2022
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716645/
https://www.ncbi.nlm.nih.gov/pubmed/36695459
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.48.2200890
work_keys_str_mv AT pittalissilvia resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022
AT mazzottavalentina resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022
AT orchinicoletta resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022
AT abbateisabella resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022
AT gagliardiniroberta resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022
AT gennaroelisabetta resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022
AT faticoniaugusto resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022
AT pisellipierluca resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022
AT rozeragabriella resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022
AT cicalinistefania resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022
AT maggifabrizio resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022
AT girardienrico resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022
AT vaiafrancesco resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022
AT antinoriandrea resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022
AT purovincenzo resultsofaninterventionalhivtestingprogrammeinthecontextofampoxformerlymonkeypoxvaccinationcampaigninlatiumregionitalyaugusttooctober2022

Ejemplares similares